[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2042 Introduced in House (IH)]

111th CONGRESS
  1st Session
                                H. R. 2042

 To authorize additional appropriations to the National Institutes of 
  Health for research on the early detection of and the reduction of 
              mortality rates attributed to breast cancer.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             April 22, 2009

  Mrs. Lowey introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
 To authorize additional appropriations to the National Institutes of 
  Health for research on the early detection of and the reduction of 
              mortality rates attributed to breast cancer.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Better Screening Test for Women 
Act''.

SEC. 2. AUTHORIZATION OF APPROPRIATIONS FOR RESEARCH ON BREAST CANCER 
              BY THE NATIONAL INSTITUTES OF HEALTH.

    Subsection (b) of section 402A of the Public Health Service Act (42 
U.S.C. 282a) is amended--
            (1) in the heading, by striking ``Office of the Director'' 
        and inserting ``Office of the Director; Additional 
        Authorizations of Appropriations'';
            (2) by striking ``Of the amount authorized to be 
        appropriated'' and inserting the following:
            ``(1) Office of the director.--Of the amount authorized to 
        be appropriated''; and
            (3) by adding at the end the following:
            ``(2) Additional authorizations of appropriations.--
                    ``(A) Research on breast cancer.--For the purpose 
                of conducting and supporting clinical research and 
                related activities under section 417(c)(1)(B) 
                concerning early detection and screening methods for 
                breast cancer, there are authorized to be appropriated 
                $55,000,000 for each of fiscal years 2010 through 2014. 
                Such authorization of appropriations is in addition to 
                any other authorization of appropriations that is 
                available for such purpose.
                    ``(B) Research on effects of early detection of 
                breast cancer.--For the purpose of conducting and 
                supporting research and data collection regarding the 
                link between early detection of breast cancer and 
                reduction of mortality rates attributed to breast 
                cancer, there are authorized to be appropriated 
                $5,000,000 for each of fiscal years 2010 through 2014. 
                Such authorization of appropriations is in addition to 
                any other authorization of appropriations that is 
                available for such purpose.''.
                                 <all>